These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7188304)

  • 1. Ocular distribution of liposome-encapsulated epinephrine and inulin in the albino rabbit.
    Stratford RE; Yang DC; Redell MA; Lee VH
    Curr Eye Res; 1982-1983; 2(6):377-86. PubMed ID: 7188304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin.
    Lee VH; Takemoto KA; Iimoto DS
    Curr Eye Res; 1984 Apr; 3(4):585-91. PubMed ID: 6713957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics.
    Lee VH; Carson LW
    J Ocul Pharmacol; 1986; 2(4):353-64. PubMed ID: 3332286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine.
    Anderson JA; Davis WL; Wei CP
    Invest Ophthalmol Vis Sci; 1980 Jul; 19(7):817-23. PubMed ID: 7390729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
    Zhang JJ; Gao CF; Wang LY
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes in topical drug delivery.
    Schaeffer HE; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and lacrimal pharmacokinetics of eye drops of puerarin liposomes in rabbit tears].
    Deng Y; Xu J; Li X
    Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(3):301-4. PubMed ID: 20422993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular disposition of aminozolamide in the rabbit eye.
    Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
    Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes.
    Hirnle E; Hirnle P; Wright JK
    J Microencapsul; 1991; 8(3):391-9. PubMed ID: 1941446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A; Mashhour B; Puisieux F; Couvreur P; Fattal E
    J Drug Target; 1998; 6(4):309-13. PubMed ID: 9894698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine.
    Wei CP; Anderson JA; Leopold I
    Invest Ophthalmol Vis Sci; 1978 Apr; 17(4):315-21. PubMed ID: 640779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment.
    Araie M; Takase M; Sakai Y; Ishii Y; Yokoyama Y; Kitagawa M
    Jpn J Ophthalmol; 1982; 26(3):248-63. PubMed ID: 6130180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and ocular pharmacokinetics of ganciclovir liposomes.
    Shen Y; Tu J
    AAPS J; 2007 Dec; 9(3):E371-7. PubMed ID: 18170984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
    Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraocular availability of liposome encapsulated monoclonal antibodies in the rabbit model. Results of a pilot study].
    Pleyer U; Rückert D; Bachmann W; Schmidt KH; Thiel HJ
    Fortschr Ophthalmol; 1991; 88(6):870-4. PubMed ID: 1794824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux.
    Schaeffer HE; Breitfeller JM; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Oct; 23(4):530-3. PubMed ID: 7118509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium chelating agents on corneal permeability.
    Grass GM; Wood RW; Robinson JR
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):110-3. PubMed ID: 3917988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea.
    Hill JM; Kwon BS; Shimomura Y; Colborn GL; Yaghmai F; Gangarosa LP
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):243-7. PubMed ID: 6298139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.